Literature DB >> 31269386

Hepatocellular Carcinoma.

Silvestre R Duran1, Robert D B Jaquiss1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31269386     DOI： 10.1056/NEJMc1906565

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  [Identification of onco-miRNAs in hepatocellular carcinoma and analysis of their regulatory network].

Authors:  J Ye; W Xu; T Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-01-20

2.  Screening potential prognostic biomarkers for portal vein emboli in patients with hepatocellular carcinoma.

Authors:  Weijie Zhou; Da Lang Fang; Yongfei He
Journal:  J Gastrointest Oncol       Date:  2021-08

3.  Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma.

Authors:  Tong Lin; E Zhang; Zhimei Lin; Lisheng Peng
Journal:  Int J Gen Med       Date:  2021-11-30

4.  PNO1 regulates autophagy and apoptosis of hepatocellular carcinoma via the MAPK signaling pathway.

Authors:  Zhiqiang Han; Dongming Liu; Lu Chen; Yuchao He; Xiangdong Tian; Lisha Qi; Liwei Chen; Yi Luo; Ziye Chen; Xiaomeng Hu; Guangtao Li; Linlin Zhan; Yu Wang; Qiang Li; Peng Chen; Zhiyong Liu; Hua Guo
Journal:  Cell Death Dis       Date:  2021-05-28       Impact factor: 8.469

5.  DNA Primase Subunit 1 Expression in Hepatocellular Carcinoma and Its Clinical Implication.

Authors:  Yipeng Zhang; Lijun Li; Renzhi Liu; Changchun Zeng
Journal:  Biomed Res Int       Date:  2020-08-22       Impact factor: 3.411

6.  Impact of regulatory T cells on the prognosis of hepatocellular carcinoma: A protocol for systematic review and meta analysis.

Authors:  Xinhui Shi; Qisong Li; Yungang Wang
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

7.  A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma.

Authors:  Zaoqu Liu; Yuyuan Zhang; Chengcheng Shi; Xueliang Zhou; Kaihao Xu; Dechao Jiao; Zhenqiang Sun; Xinwei Han
Journal:  J Transl Med       Date:  2021-01-06       Impact factor: 5.531

8.  ZWINT is a Promising Therapeutic Biomarker Associated with the Immune Microenvironment of Hepatocellular Carcinoma.

Authors:  Tong Lin; Yingzhao Zhang; Zhimei Lin; Lisheng Peng
Journal:  Int J Gen Med       Date:  2021-10-30

9.  Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma.

Authors:  Shanzhou Huang; Chuanzhao Zhang; Chengjun Sun; Yuchen Hou; Yixi Zhang; Nga Lei Tam; Zekang Wang; Jia Yu; Bowen Huang; Hongkai Zhuang; Zixuan Zhou; Zuyi Ma; Zhonghai Sun; Xiaoshun He; Qi Zhou; Baohua Hou; Linwei Wu
Journal:  Aging (Albany NY)       Date:  2020-02-11       Impact factor: 5.682

10.  CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.

Authors:  Tong Lin; E Zhang; Pei-Pei Mai; Ying-Zhao Zhang; Xiang Chen; Li-Sheng Peng
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.